Jazz buys Virginia biotech firm in deal valued at up to $312.5M
August 13, 2019 at 12:59 PM EDT
The company Jazz bought is developing a new treatment for a a nervous system disorder that causes rhythmic shaking.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|